Cellares

Cellares develops and operates integrated technologies for automated cell therapy manufacturing and quality control.

Health and bio Manufacturing and industrial

Latest funding

$257M Series B+ · January 28, 2026

Led by Koch Disruptive Technologies · Source: Yahoo Finance

Latest round on record: Series B+, July 2026, amount undisclosed.

Total raised: $357M across 3 sourced rounds

All 4 rounds ↓

Website: cellares.com.

LinkedIn: cellares-corporation.

Categories: Health and bio Manufacturing and industrial.

Sectors: Biotechnology, Life Science, Manufacturing, Medical, Therapeutics.

Stage: Series B+.

Based in: South San Francisco, United States.

Founded: 2019.

Total raised: $357M in 3 sourced rounds.

Last round: Jul 16, 2026 · 122 days ago.

Headcount: 101–250 employees.

On Recent Funding since: Sep 29, 2026.

Signals

Website registeredMar 8, 2019 (7 years old)

About Cellares

It offers the Cell Shuttle platform for manufacturing and the Cell Q platform for quality control. Cellares' customers are biopharmaceutical partners who use its services to scale development to industrial production and expand manufacturing capacity.

TIMELINE · MONEY RAISED

Cellares | 573 days from website to first raise on record

Raised $357M in 3 sourced rounds·1 signal before the first raise

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

Date	Round	Amount	Lead	Source
Jul 16, 2026	Series B+	undisclosed	EEclipse	fundraisingfox.com
Jan 28, 2026	Series B+	$257M	KKoch Disruptive Technologies	Yahoo Finance
May 5, 2021	Series B+	$82M	DDecheng Capital	medcitynews.com
Oct 1, 2020	Series A	$18M	EEclipse	startupintros.com

Timeline

March 8, 2019
Website created

Founders and team

FG
Fabian Gerlinghaus Co-Founder & CEO

LinkedIn · source: cellares.com
AP
Alex Pesch Founder

LinkedIn · also Synthego
OK
Omar Kurdi Co-Founder & President

LinkedIn · source: cellares.com
AS
Ali Soleymannezhad Chief Commercial Officer
JT
John Tomtishen VP of Operations
JB
Jonathan Butler General Counsel & Secretary
JM
Justin McAnear CFO

Investors

Companies like Cellares

CCellular Origins$40M Series A · Jan 2026
LLimula$6.8M Seed · Jun 2024
AAugust Bioservices$65M Series B+ · Dec 2022
PProxima Fusion$468M Series B+ · Jul 2026
MManex AI$9.14M Seed · Jun 2025
RRESONIKSSeed · May 2026

Other companies backed by Eclipse

HHumble$51M Series A · Nov 2026
BBedrock Robotics$600M Series B+ · Oct 2026
PPeak Energy$108M Series B+ · Oct 2026
RReliable Robotics$115M Series B+ · Oct 2026
SStand$70M Series B+ · Oct 2026
OOxide Computer Company$445M Series B+ · Oct 2026

Eclipse portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/cellares (get a free API key).